當(dāng)前位置 ： Millipore >>> Millipore/15-107 | MAPK Pathway 1 Explorer Antibody MiniPack/15-107/3 vials/Pk
Millipore/15-107 | MAPK Pathway 1 Explorer Antibody MiniPack/15-107/3 vials/Pk
  • Millipore/15-107 | MAPK Pathway 1 Explorer Antibody MiniPack/15-107/3 vials/Pk

Millipore/15-107 | MAPK Pathway 1 Explorer Antibody MiniPack/15-107/3 vials/Pk

價(jià)格: ￥2832.00 市場(chǎng)價(jià): 4720.00
貨號(hào): 15-107
品牌: Millipore
規(guī)格
數(shù)量
庫(kù)存(0)
特別 提示
代購(gòu)產(chǎn)品：無(wú)質(zhì)量問(wèn)題不接受退換貨，下單前請(qǐng)仔細(xì)核對(duì)信息。
下單后請(qǐng)及時(shí)聯(lián)系客服核對(duì)商品價(jià)格，訂單生效后再付款。
資深產(chǎn)品顧問(wèn)
咨詢顧問(wèn)

全國(guó)免費(fèi)服務(wù)熱線

4000-520-616

  • 自營(yíng)商城 一站式服務(wù)
  • 廠家直采 剔除溢價(jià)
  • 品質(zhì)甄選 正品保證
  • 嚴(yán)控流程 只做188精品
  • 極速物流 如約送貨
  • 詳情
  • 使用說(shuō)明
  • 常見(jiàn)問(wèn)題
    • Description
      CatalogueNumber15-107
      BrandFamilyUpstate
      TradeName
      • Upstate
      DescriptionMAPKPathway1ExplorerAntibodyMiniPack
      AlternateNames
      • OncogeneRAF1
      • rafproto-oncogeneserine/threonineproteinkinase
      BackgroundInformationPathwayExplorerAntibodyMiniPack:
      EachPathwayExplorerAntibodyMinipackcontainsthreerelatedantibodiesaspartofasignalingcascadeoracombinationoftotalandphosphorylatedformsofkeysignalingtargets.Eachofthethreeantibodiesare30%theoriginalpacksize.FullsizeversionsofeachofthePathwayExplorerantibodiesareavailableforsaleindividuallyunderthesamecatalognumberwiththeremovalof“SP”offofeachone(e.g.05-591SPcanbeorderedas05-591).

      Erk1/2:
      Erk(Extracellularsignal-RelatedKinase)isafamilyoftwo,highlyhomologousproteinsdenotedasErk1(p44,MAPK3)andErk2(p42,MAPK1)thatbothfunctioninthesamepathway.ThetwoproteinsareoftenreferredtocollectivelyasErk1/2orp44/p42MAPkinase.TheErkpathwayisconsideredtheclassical,canonicalMAPK(Mitogen-ActivatedProteinKinase)signalingpathway.Itisanevolutionarilyconservedpathwaythatcontrolsandisacriticalregulatorofthegrowthandsurvivalthroughthepromotionofcellproliferationandthepreventionofapoptosis.Erkisinvolvedinthecontrolofmanyfundamentalcellularprocessesincludingcellproliferation,survival,differentiation,apoptosis,motilityandmetabolism.Erkisactivatedbygrowthfactorstimulationofreceptortyrosinekinases(RTKs),GPCR,and/orintegrinstimulation.ThisactivatestheRas-Raf-MEK-Erkpathwaythatresultsinthephosphorylation/activationofErk1/2(p44/p42)ontheTxYmotif(Thr202/Tyr204andThr185/Tyr187forErk1&Erk2,respectively).

      Raf:
      TheRafproteins(A-Raf,B-Raf,Raf-1/c-Raf)areSer/ThrkinaseswithhomologytothePKCfamily,containinganN-terminalregulatorydomainandaC-terminalcatalyticdomain.Raf(MAPKinaseKinaseKinase)isthetopkinaseinthecanonicalMAPKpathway.MembersoftheRaffamilybindtoactivatedRas.Ras,initsGTP-boundactivestate,activatesthekinaseactivityofRaf.ThisresultsinRaftranslocationtotheplasmamembraneandactivation.Onceactivated,RafthenbindstoandactivatesMEK(MAPKinaseKinase)byphosphorylatingitonthetworesiduemotif.ItisthoughtthatB-RafmightbethepredominantactivatorofMEKandthatRaf-1hasaroleinprotectionagainstapoptosis;aprocessthatdoesnotrequireeitheritskinaseactivityoritsactivationofMEK.TheregulationofalargenumberofcellularprocessesaredependentupontheactivationstateofERK,sothecontrollingofthispathwaycouldhaveprofoundeffectsonvariousdiseases.ActivationofRaf-1involvesphosphorylationofSer338/339andTyr340/341.ActivatingmutationsofB-Rafthatdisruptitsauto-inhibitionloophavebeenimplicatedinanumberofcancers,includingmelanomaandcoloncancer.

      MEK1/MEK2:
      MAPKinase/ErkKinase(MEK),alternativelyknownasMKK,isatruedual-specificitykinase,inthatitphosphorylatestheMAPkinases(Erk1/2;p44/p42))onboththeThrandTyroftheactivationmotifTEY.Invitro,thetyrosinephosphorylationisfavored,whereasinvivobothphosphorylationeventsappeartooccursimultaneously.Thissuggeststhatanadditionalfactorispresentincellstofacilitatethereaction.MEK1andMEK2areactivatedbyphosphorylationoftwoserineresidues(Ser218/222inMEK1andSer222/226inMEK2),whicharesubstratesfortheRaffamilyofkinases.MutationofthephosphorylationsitesfromSertoAspcreatesaproteinwithconstitutivekinaseactivity,whichwhenexpressedincellsisabletocausetransformation.


      *Seefullsizeversionsforcorrespondingreferences.
      ProductInformation
      Components
      • 05-538SPAnti-phospho-Raf-1(Ser338)
      • 05-747SPAnti-phospho-MEK1(Ser218/222)/MEK2(Ser222/226)
      • 05-797RSPAnti-phospho-Erk1/2
        (Thr202/Tyr204,Thr185/Tyr187),recombinantcloneAW39R
      FormatPurified
      Control
      • 05-538SP:3T3/NIHcells
      Presentation3individualtubescontainingeitherAnti-phospho-Raf-1(Ser338);orAnti-phospho-MEK1(Ser218/222)/MEK2(Ser222/226);Anti-phospho-Erk1/2
      (Thr202/Tyr204,Thr185/Tyr187),recombinantcloneAW39R
      PropertiesEachvialis30%thesizeoftheparentcatalognumber
      StorageandShippingInformation
      StorageConditionsStablefor1yearat-20°Cfromdateofreceipt.
      HandlingRecommendations:Uponreceipt,andpriortoremovingthecap,centrifugethevialandgentlymixthesolution.Aliquotintomicrocentrifugetubesandstoreat-20°C.Avoidrepeatedfreeze/thawcycles,whichmaydamageIgGandaffectproductperformance.
      Applications
      ApplicationThisAntibodypackcontainsAnti-phospho-Raf-1Antibody(Ser338),Anti-phospho-MEK1Antibody(Ser218/222)/MEK2(Ser222/226),Anti-phospho-Erk1/2Antibody(Thr202/Tyr204,Thr185/Tyr187),validatedforuseinIF,Flow,WB,Multiplexing
      KeyApplications
      • Immunofluorescence
      • FlowCytometry
      • WesternBlotting
      • Multiplexing
      ApplicationNotes05-797RSP:ImmunofluorescenceAnalysis:A431cellswerefixed,permABIlizedanddualstainedwithanti-phospho-Erk.

      FlowCytometryAnalysis:Jurkatcellswerefixed,permeablized,andstainedwithanti-phospho-Erk1/2(Thr202/Tyr204,Thr185/Tyr187).


      BIOLOGicalInformation
      Immunogen05-797RSP:PhosphorylatedpeptideencompassingtheTxYmotifintheactivationloopofErk1andErk2.;05-747SP:KLH-conjugated,syntheticpeptidecontaining…DpSMANpSF…inwhichpScorrespondstophosphorylatedaminoacids218and222ofhumanMEK1.Theimmunizingsequenceishighlyconserved.;05-538SP:KLH-conjugated,syntheticpeptideencompassingandincludingphosphorylatedSer338ofhumanRaf-1.Theimmunizingsequenceisidenticalinratandchickenandhas12/13identicalaminoacidsinXenopus.
      EpitopePleaseseerelevantdatasheet.
      Clone05-797RSP:AW39R
      Concentration05-538SP:1mg/mL
      Specificity05-797RSP:RecognizesErk1&2onlywhenduallyphosphorylatedonitsTxYactivationmotif.;05-747SP:PhosphorylatedMEK1/MEK2;05-538SP:RecognizesRaf-1phosphorylatedatSerine338
      SpeciesReactivity
      • Human
      • Mouse
      • Rat
      • Chicken
      • Xenopus
      SpeciesReactivityNote05-538SP:Mouseandhuman.
      Predictedtocrossreactwithrat,chickenandXenopusbasedonsequencehomology.
      EntrezGeneNumber
      GeneSymbol
      • MAP2K1
      • PRKMK1
      • MKK1
      • MAPKK1
      • MEK1
      • RAF1
      • cRaf
      • Raf-1
      • c-Raf
      • RAF
      • CRAF
      • C-RAF
      • MAPK3
      • ERK1
      • p44
      • P44ERK
      • P44MAPK
      • Erk2
      • MAPK1
      • P42MAPK
      • P42ERK
      Modifications
      • Phosphorylation
      UniProtNumber
      UniProtSummaryRaf-1:
      FUNCTION:Involvedinthetransductionofmitogenicsignalsfromthecellmembranetothenucleus.PartoftheRas-dependentsignalingpathwayfromreceptorstothenucleus.ProtectscellsfromapoptosismediatedbySTK3.
      CATALYTICACTIVITY:ATP+aprotein=ADP+aphosphoprotein.
      COFACTOR:Binds2zincionspersubunit.
      SUBUNITSTRUCTURE:InteractswithRasproteins.TheinteractionwithRasisantagonizedbyRIN1.WeaklyinteractswithRIT1Bysimilarity.InteractswithSTK3,whichinhibitsitspro-apoptoticactivity.
      TISSUESPECIFICITY:Inskeletalmuscle,isoform1ismoreabundantthanisoform2.
      POST-TRANSLATIONALMODIFICATION:PhosphorylateduponDNAdamage,probablybyATMorATR.PhosphorylationatThr-269increasesitskinaseactivity.
      INVOLVEMENTINDISEASE:DefectsinRAF1arethecauseofNoonansyndrometype5(NS5)[MIM:611553].Noonansyndrome(NS)isadisordercharacterizedbydysmorphicfacialfeatures,shortstature,hypertelorism,cardiacanomalies,deafness,motordelay,andableedingdiathesis.Itisageneticallyheterogeneousandrelativelycommonsyndrome,withanestimatedincidenceof1in1000-2500livebirths.Ref.24Ref.25
      DefectsinRAF1arethecauseofLEOPARDsyndrometype2(LEOPARDsyndrome-2)[MIM:611554].LEOPARDsyndromeisanautosomaldominantdisorderallelicwithNoonansyndrome.TheacronymLEOPARDstandsforlentigines,electrocardiographicconductionabnormalities,ocularhypertelorism,pulmonicstenosis,abnormalitiesofgenitalia,retardationofgrowth,anddeafness.

      MEK1:
      FUNCTION:CatalyzestheconcomitantphosphorylationofathreonineandatyrosineresidueinaThr-Glu-TyrsequencelocatedinMAPkinases.ActivatesERK1andERK2MAPkinases.
      CATALYTICACTIVITY:ATP+aprotein=ADP+aphosphoprotein.
      ENZYMEREGULATION:Activatedbyphosphorylation.
      SUBUNIT:InteractswithMORG1(Bysimilarity).InteractswithYersiniayopJ.
      PTM:PhosphorylationonSer/ThrbyMAPkinasekinasekinases(RAForMEKK1)regulatespositivelythekinaseactivity.
      PTM:AcetylationbyYersiniayopJpreventsphosphorylationandactivation,thusblockingtheMAPKsignalingpathway.
      DISEASE:DefectsinMAP2K1areacauseofcardiofaciocutaneoussyndrome(CFCsyndrome)[MIM:115150];alsoknownascardio-facio-cutaneoussyndrome.CFCsyndromeischaracterizedbyadistinctivefacialappearance,heartdefectsandmentalretardation.Heartdefectsincludepulmonicstenosis,atrialseptaldefectsandhypertrophiccardiomyopathy.Someaffectedindividualspresentwithectodermalabnormalitiessuchassparse,friablehair,hyperkeratoticskinlesionsandageneralizedichthyosis-likecondition.TypicalfacialfeaturesaresimilartoNoonansyndrome.Theyincludehighforeheadwithbitemporalconstriction,hypoplasticsupraorbitalridges,downslantingpalpebralfissures,adepressednasalbridge,andposteriorlyangulatedearswithprominenthelices.TheinheritanceofCFCsyndromeisautosomaldominant.
      SIMILARITY:Belongstotheproteinkinasesuperfamily.STESer/Thrproteinkinasefamily.MAPkinasekinasesubfamily.
      SIMILARITY:Contains1proteinkinasedomain.

      Erk2:
      FUNCTION:CatalyzestheconcomitantphosphorylationofathreonineandatyrosineresidueinaThr-Glu-TyrsequencelocatedinMAPkinases.ActivatesERK1andERK2MAPkinases.
      CATALYTICACTIVITY:ATP+aprotein=ADP+aphosphoprotein.
      ENZYMEREGULATION:ActivatedbyphosphorylationontyrosineandthreonineinresponsetoinsulinandNGF.Bothphosphorylationsarerequiredforactivity
      SUBUNITSTRUCTURE:InteractswithMORG1Bysimilarity.BindstoHIV-1NefthroughitsSH3domain.Thisinteractioninhibitsitstyrosine-kinaseactivity.InteractswithitssubstratesHSF4andARHGEF2.InteractswithNISCH.
      DOMAIN:TheTXYmotifcontainsthethreonineandtyrosineresidueswhosephosphorylationactivatestheMAPkinases.
      PTM:DuallyphosphorylatedonThr-185andTyr-187,whichactivatestheenzyme.
      MolecularWeight05-797RSP:42and44kDa;05-747SP:45kDa;05-538SP:74kDa
      PhysicochemicalInformation
      Dimensions
      MaterialsInformation
      MaterialsInformation
    售后保障
    螞蟻淘生物188，秉承螞蟻淘一貫的嚴(yán)謹(jǐn)態(tài)度，由螞蟻淘公司專業(yè)人員負(fù)責(zé)品控、采購(gòu)、物流、銷售、售后，保障正品優(yōu)質(zhì)。以“快速好省，為科研提供好產(chǎn)品、好價(jià)格”為理念，直接鏈接原廠家，從全國(guó)各地原制造商嚴(yán)格挑選188款科研精品，剔除品牌溢價(jià)，188生物新電商，把好的產(chǎn)品帶給科研！? 力求給你最優(yōu)質(zhì)的商品。
  • Q：生物188產(chǎn)品正品保障嗎？
    A：生物188質(zhì)量把控人員具有十年的從業(yè)經(jīng)驗(yàn)，在業(yè)界享有良好的口碑；自營(yíng)商城，直接從廠家采購(gòu)， 自己的團(tuán)隊(duì)負(fù)責(zé)國(guó)際物流和清關(guān)，中間沒(méi)有第三方，所有流程嚴(yán)格把控，100%保證正品，假一罰十。

    Q：下單后可以修改訂單嗎？
    A：下單后的商品付款之前可以修改；訂單付款成功，需要聯(lián)系我們客服進(jìn)行修改；客服電話：4000-520-616

    Q：可以開(kāi)發(fā)票嗎？
    A：本網(wǎng)站所售商品都是正規(guī)清關(guān)，均開(kāi)具16%正規(guī)發(fā)票，發(fā)票金額含配送費(fèi)金額，另有說(shuō)明的除外。

    Q：商品幾天可以發(fā)貨？
    A：生物188商品，全部現(xiàn)貨銷售，付款后即可發(fā)貨,一般一周內(nèi)送達(dá)！

    Q：如何聯(lián)系商家？
    A：有任何問(wèn)題夠可以電話咨詢我們，全國(guó)24小時(shí)免費(fèi)服務(wù)熱線：4000-520-616 或聯(lián)系我們的在線客服QQ：1570468124

    Q：收到的商品少了/發(fā)錯(cuò)了怎么辦？
    A：同個(gè)訂單購(gòu)買多個(gè)商品可能會(huì)分為一個(gè)以上包裹發(fā)出，可能不會(huì)同時(shí)送達(dá)，建議查看訂單詳情是否是 部分發(fā)貨狀態(tài)；如未收到，可聯(lián)系在線客服或者致電4000-520-616。

    Q：退換貨/維修需要多長(zhǎng)時(shí)間？
    A：一般情況下，退貨處理周期為客戶收到產(chǎn)品一個(gè)月內(nèi)（以快遞公司顯示簽收時(shí)間為準(zhǔn)），包裝規(guī)格、 數(shù)量、品種不符，外觀毀損、短缺或缺陷，請(qǐng)?jiān)谑盏截?4小時(shí)內(nèi)申請(qǐng)退換貨；特殊商品以合同條款為準(zhǔn)。

何為188

極簡(jiǎn)而嚴(yán)謹(jǐn)，我們僅銷售188款生物醫(yī)學(xué)科研用品，款款都是爆款；因?yàn)樯偎跃劢梗劢拐邕x每一款產(chǎn)品，聚焦服務(wù)每一位客戶!

關(guān)注我們 :

點(diǎn)擊QQ聯(lián)系我們
生物188微信

關(guān)注188微信公眾號(hào)

獲取最新優(yōu)惠活動(dòng)通知